ClinicalTrials.Veeva

Menu

Skin Sympathetic Nerve Activity and Cardiac Arrhythmia (SKNA)

U

University Hospital of Bordeaux

Status

Completed

Conditions

Persistent Atrial Fibrillation
Sudden Death
Ventricular Tachycardia

Treatments

Device: SKNA recording

Study type

Interventional

Funder types

Other

Identifiers

NCT04918303
CHUBX 2020/55

Details and patient eligibility

About

Sympathetic tone is important in cardiac arrhythmogenesis. The simultaneous recording of sympathetic nerve activity (SNA) and electrocardiogram (ECG) was obtained by invasive method. The purpose of this protocol is to further develop this recording method to turn it into a new non-invasive tool for arrhythmia prediction and detection. This method may also be useful in validating the results of surgical procedures aimed at sympathetic denervation

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient hospitalized at Bordeaux University Hospital for sudden death, ventricular tachycardia, persistent or paroxysmal atrial fibrillation treated by ablation and/or vein of Marshall ethanol infusion

Exclusion criteria

  • pregnancy,
  • patient under 18 year old,
  • patient with a cardiac stimulation device

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

SKNA group
Experimental group
Treatment:
Device: SKNA recording

Trial contacts and locations

1

Loading...

Central trial contact

Mélèze Hocini, MD; Maëlle Vallade

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems